News

Impactful Rally Benefit Bash Raises Over $4 Million for Children

Impactful Rally Benefit Bash Raises Over $4 Million for Children

Rally Foundation's Remarkable Fundraising Event

Celebrating 20 years of dedication towards advancements in research, the Rally Foundation for Childhood Cancer Research continues to instill hope for children diagnosed with cancer daily.

This past Friday, the Rally Foundation hosted its annual Rally Benefit Bash, a much-anticipated gathering supported by notable corporate sponsors. The generous contributions from Delta Air Lines, Altium Packaging, and RTX have significantly uplifted the event's mission to propel research into better treatments and cures specifically aimed at childhood cancers.

This year's event was monumental. It successfully garnered $4,014,225 in essential funds for childhood cancer research, bringing the cumulative total raised by the event over the years to an impressive $24.5 million.

A Night of Inspiration and Hope

The evening encapsulated powerful testimonies from inspiring figures like Rally Kid Keren, who has triumphed over three types of cancer, and Rally Kid Asher, who continues to battle brain cancer. Their courageous narratives reminded attendees of the critical need for ongoing support and research aimed at aiding children confronting cancer.

Dean Crowe, the Founder and CEO of the Rally Foundation, expressed heartfelt gratitude towards everyone present, emphasizing the collective effort that made the evening a success. “The generosity and compassion displayed during this year's Benefit Bash have been profoundly inspiring. As Rally honors two decades dedicated to advancing research, we're determined to secure the breakthroughs essential for offering hope and healing to young warriors battling cancer,” he stated.

Celebrating Leadership and Commitment

This year marked a special acknowledgment for Dean Crowe, who received the Rally for Research Award, recognizing his two decades of unwavering commitment toward supporting children in their fight against cancer.

The Corporate Chairs for the 2025 Rally Benefit Bash were recognized as Erik Snell, Executive Vice President and Chief Customer Experience Officer at Delta Air Lines, and Hermann Elger, Chief Executive Officer of Forbes Travel Guide. Both leaders shared insights about Rally’s invaluable work.

“Rally Foundation embodies hope and compassion during the most challenging times for families grappling with childhood cancer,” said Erik Snell. “The enthusiasm and unity displayed here tonight truly highlight the impactful change we can achieve together.”

Similarly, Hermann Elger remarked, “I’m honored to stand by the Rally Foundation as it paves the way for significant strides in research that genuinely transform lives and inspire hope for children and families battling cancer.”

Recognizing Supportive Leadership

The event also honored its Chairs Emeritus, including prominent leaders such as Ed Bastian, CEO of Delta Air Lines; Jeff Arnold, Executive Chairman of Sharecare; and Dr. Henry Ting, Senior Vice President at Delta Air Lines, acknowledging their ongoing contributions and leadership.

Other significant sponsors of the 2025 Rally Benefit Bash included esteemed organizations like Airbus, American Express, Deloitte, and Nike, further highlighting the widespread support for childhood cancer research efforts.

About Rally Foundation for Childhood Cancer Research

Every day, an alarming number of 47 children in the U.S. are diagnosed with cancer. Founded in 2005, the Rally Foundation for Childhood Cancer Research, a recognized nonprofit organization, proudly marks its 20th anniversary in 2025, celebrating decades of commitment to transforming the future of childhood cancer treatment.

Rally actively empowers volunteers across the nation to engage in efforts that raise awareness and funds, devoted to discovering improved treatments that potentially minimize long-term side effects and lead to cures.

Over the last 20 years, Rally Foundation has awarded $40.5 million in research grants, and successfully secured over $317.5 million from federal programs directed at researchers focusing on childhood cancer. Their remarkable achievements have positioned Rally as the leading childhood cancer organization globally, with 93 cents of every dollar raised directly supporting its mission.

Frequently Asked Questions

What is the Rally Benefit Bash?

The Rally Benefit Bash is an annual fundraising event hosted by the Rally Foundation to support childhood cancer research and treatment innovations.

How much money was raised this year?

This year, the event raised $4,014,225 for childhood cancer research, contributing significantly to its overall fundraising history.

Who was honored during the event?

Dean Crowe, the Founder and CEO of Rally, received the Rally for Research Award for his leadership over two decades.

What organizations were main sponsors for the event?

Major sponsors included Delta Air Lines, Altium Packaging, and RTX, alongside other notable partners.

How can I learn more about Rally Foundation?

To learn more about the Rally Foundation for Childhood Cancer Research, visit their official website and follow them on social media for updates and further information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Solis Agrosciences Gains Series A Funding to Drive Growth Forward

Updated Category News Views 272

Solis Agrosciences Gains Series A Funding to Drive Growth Forward Solis Agrosciences, a prominent name in the Agtech sector, has announced a significant milestone in its journey of innovation and growth. The company has successfully secured Series A funding from Cultivation Capital, an investment that promises to amplify its business operations and expand its array of...

Continue Reading
Blink Charging: Milestone Achievements and Future Outlook

Updated Category News Views 283

Update on Blink Charging and Its Stock Performance Blink Charging Co. (NASDAQ: BLNK) shares saw an upward trend recently, as the company proudly announced it surpassed 100,000 electric vehicle (EV) chargers sold, deployed, or contracted globally. This significant accomplishment highlights Blink's growth in the EV infrastructure sector. The company's success can be...

Continue Reading
Vanguard Unveils Innovative Active Equity ETF Range

Updated Category News Views 228

Vanguard Launches New Active Equity ETFs Vanguard has recently introduced three active equity ETFs aimed at enhancing investor portfolio options. The newly launched funds are the Vanguard Wellington U.S. Value Active ETF (VUSV), Vanguard Wellington U.S. Growth Active ETF (VUSG), and Vanguard Wellington Dividend Growth Active ETF (VDIG), each managed by the esteemed...

Continue Reading
New COVID-19 Vaccine by Pfizer and BioNTech Shows Promise

Updated Category News Views 244

Revamped Approach to COVID-19 Vaccination In a noteworthy advancement in the fight against the COVID-19 pandemic, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) are set to introduce an LP.8.1-adapted monovalent COVID-19 vaccine following a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)....

Continue Reading
Gold's Steady Climb Amid Geopolitical Tensions and Economic Shifts

Updated Category News Views 210

Gold Rises for Third Consecutive Session Gold (XAU/USD) has shown a steady increase of over 0.32%, reflecting a notable rise in safe-haven demand driven by global trade tensions. Investors remain concerned about the stability of global supply chains, making gold a popular choice during times of uncertainty. The yellow metal typically shines as a safe-haven asset when...

Continue Reading